Navigation Links
InspireMD Reports Financial Results for Quarter Ended September 30, 2013
Date:11/11/2013

ers us greater flexibility to accelerate these programs," concluded Mr. Milinazzo.

Operational Overview On October 29, 2013, the Company announced the 12-month follow up results from the MASTER trial for its MGuard Embolic Protection Stent (EPS).The findings showed that the novel MGuard EPS provides a significant acute advantage in reducing ST segment elevation versus traditional bare metal and drug eluting stents. As a result, MGuard may hold the potential to prolong the survival of heart attack victims, as evidenced by the 12-month data.  The 12-month follow up results are an important data point for physicians evaluating the MGuard, as the first year is an important period for evaluating a patient who has received a stent during a heart attack.  As the Company now has this data in hand, it intends to ramp commercial activity for the remainder of 2013 and 2014.

The Company continues enrollment in its MASTER II clinical trial to evaluate the safety and effectiveness of the MGuard™ Prime EPS in patients suffering from ST Elevation Myocardial Infarction (STEMI). In total, the multi-center, randomized trial is expected to include up to 70 sites in the U.S. and Europe and as many as 1,114 patients. The results are intended to support the Company's Investigational Device Exemption (IDE) application with the U.S. Food and Drug Administration (FDA) to market the MGuard™ Prime MicroNet™ covered coronary stent system in the U.S.

While the MASTER II trial is fully funded, the Company took additional steps to secure strategic financing and protect shareholder value.  On October 24th, the Company announced it had secured $10 million in venture debt to support expanding its emerging clinical research and product development efforts.  The Company also put into place a one year stockholder rights plan which the Board believed was prudent in order to protect shareholders' interests. 

Quarter Ended S
'/>"/>

SOURCE InspireMD
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. InspireMD Announces First Quarter 2012 Financial Results
2. InspireMD Announces Positive 3-Year Results from Extended MAGICAL trial
3. InspireMD to Present at Inaugural Marcum Microcap Conference on June 20th in New York
4. InspireMD to Present at Harvard Investors Group on June 27 in New York
5. InspireMD Announces Positive Results From MGuard(TM) Stent MASTER Trial for Emergency Treatment of Heart Attack Patients
6. InspireMD Reports Results For Period Ending Sept. 30, 2012
7. Positive Results of InspireMDs MASTER Trial to be Published on November 6 in Journal of American College of Cardiology
8. InspireMD to Discuss MGuard(TM) and the MASTER Randomized Trial Results at the ICI 2012 Meeting
9. InspireMD Reports Results for Period Ended Dec. 31, 2012
10. InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock
11. InspireMD Receives CE Mark Approval for Carotid Embolic Protection Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... On Aug. 20, at its annual meeting in ... voted on and approved a delegate resolution opposing the ... Cannabis Corp., a leading Canadian licensed producer of medicinal ... The CMA is quite right to point out that ... material, including medicinal cannabis. While some patients, particularly those ...
(Date:8/22/2014)... Equity Research highlights Epizyme (Nasdaq: EPZM - Free Report ... PNRA - Free Report ) as the Bear of the Day. ... FOLD - Free Report ), Sanofi (NYSE: SNY - ... ). Here is a synopsis of all five stocks: ... The biotech bull market is far from over due to ...
(Date:8/22/2014)... , Aug. 22, 2014  Cannabis Science, Inc. ... formulation-based drug development and related consulting, is pleased ... international medical cannabis conference taking place at the ... , on October 22, 2014.  The multilingual ... such as researchers, health professionals, and patients, to ...
Breaking Medicine Technology:Bedrocan Canada Statement Regarding Canadian Medical Association Motion on Smoking Marijuana 2Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 2Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 3Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 4Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 5Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 6Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 3
... ARBOR, Mich., Nov. 9 Thomson Reuters ... a leading clinical surveillance solution that enables hospitals to ... improve clinical quality and reduce total cost of treatment. ... at no additional cost. , CareFocus 2.0 ...
... Nov. 9 Arcadia Resources, Inc. (NYSE Amex: ... care services under the Arcadia HealthCare(SM) brand, has appointed ... will replace Tres Lund who announced his resignation from ... http://www.newscom.com/cgi-bin/prnh/20091109/DE07521 ) , Goldsmith is the Daniel ...
Cached Medicine Technology:Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3Arcadia Resources Names Stephen Goldsmith to Board of Directors 2Arcadia Resources Names Stephen Goldsmith to Board of Directors 3
(Date:8/23/2014)... 23, 2014 Hundreds of Wright ... behalf of individuals who were allegedly harmed by ... continue to move forward in the U.S. District ... reports. According to an Order dated August 19th, ... that would allow the litigation’s first case to ...
(Date:8/23/2014)... NewYork (PRWEB) August 23, 2014 GBI ... latest research: “Critical Care Therapeutics in Major Developed Markets ... Recombinant Products to Drive Market”, which provides in-depth analysis ... France, Germany, Italy, Spain, Japan and Canada. The report ... with market forecasts to 2020. It covers critical care ...
(Date:8/23/2014)... California (PRWEB) August 23, 2014 Pixel Film ... themes, announced today the release of ProIntro Vol.3, a customizable ... a fresh and professional tile just by dragging ProIntro Vol.3 ... Studios. "ProIntro Vol.3 is a definite time saver and i ... intro pack with 30 beautifully designed titles made with Final ...
(Date:8/23/2014)... 2014 Youth substance abuse is a ... different in Houston, TX. Substance abuse can happen to ... drug and alcohol dependency in higher numbers than ever ... substance abuse, but don’t know where to find professional ... be a challenge because most treatment options are designed ...
(Date:8/23/2014)... vacation is almost over and before we know it schools ... school supplies and a new wardrobe might take precedence over ... also spend some time brushing up on bed bug prevention ... heavily populated places,” said Randy Rupert, Bed Bug Team Lead ... for bed bugs to take up residence.” , An already ...
Breaking Medicine News(10 mins):Health News:Wright Conserve Hip Lawsuits Move Forward, as Federal Court Issues Order Pertaining to Bellwether Trials, Bernstein Liebhard LLP Reports 2Health News:Wright Conserve Hip Lawsuits Move Forward, as Federal Court Issues Order Pertaining to Bellwether Trials, Bernstein Liebhard LLP Reports 3Health News:Wright Conserve Hip Lawsuits Move Forward, as Federal Court Issues Order Pertaining to Bellwether Trials, Bernstein Liebhard LLP Reports 4Health News:Critical Care Therapeutics in Major Developed Markets to 2020 | Researchmoz 2Health News:Critical Care Therapeutics in Major Developed Markets to 2020 | Researchmoz 3Health News:A new plugin was announced today, ProIntro Vol.3 from Pixel Film Studios for Final Cut Pro X 2Health News:New Houston Hotline Assisting Juveniles in Locating Dependable Rehabilitation Help 2Health News:Expert Advice for a Bed Bug-Free School Year 2
... TUESDAY, Dec. 29 (HealthDay News) -- Winter,s icy sidewalks and ... extra hazards for elderly people, experts say. , Falls are ... 65 in the United States. Some 1.8 million people aged ... in 2005, and 15,800 died from their injuries, according to ...
... , IRVING, Texas, Dec. 29 ... and the other Global Hotel Alliance brand members ... & Lymphoma Society (LLS). The luxury hotel brands from across ... Jason Harmon, an Omni and GHA associate who succumbed to lymphoma ...
... Dec. 29 Three, Two, One...Happy New Year! This ... kissing their way to a new Colgate® Wisp® Guinness World Records® ... U.S. will prepare for the New Year,s "Midnight Kiss" with Colgate® ... they attempt to set a new Guinness World Records record for ...
... ... global recovery and prevention campaign called Stop Drinking 411 to combat prevalent alcohol abuse...read ... Gaithersburg, ... launching a global recovery and prevention campaign called Stop Drinking 411 to combat prevalent ...
... , Dec. 29 The Coalition for Pulmonary Fibrosis (CPF) ... and awareness, even in a year plagued by the economic ... cause, no FDA-approved treatment, and no cure. , The CPF ... to build awareness of the disease throughout the country. ...
... ... its website to serve more effectively millions of people suffering from alcohol abuse ... ... Recovery (NIFAR®) has completely redesigned its website to serve more effectively millions of ...
Cached Medicine News:Health News:Caution Can Help Keep Elderly Safe During Winter 2Health News:Omni Hotels & Resorts and Global Hotel Alliance Partner for Charity 2Health News:Omni Hotels & Resorts and Global Hotel Alliance Partner for Charity 3Health News:Guinness World Records(R) Attempt For 'Most People Kissing Simultaneously' to Take Place This New Year's Eve 2Health News:Guinness World Records(R) Attempt For 'Most People Kissing Simultaneously' to Take Place This New Year's Eve 3Health News:New 'Stop Drinking 411' Campaign Promotes Alcohol Recovery and Prevention via Web Social Media 2Health News:New 'Stop Drinking 411' Campaign Promotes Alcohol Recovery and Prevention via Web Social Media 3Health News:Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn 2Health News:Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn 3Health News:Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn 4Health News:New NIFAR Website Offers Millions a Comprehensive Resource for Alcohol Education, Recovery, and Support 2Health News:New NIFAR Website Offers Millions a Comprehensive Resource for Alcohol Education, Recovery, and Support 3
PDA application providing a complete guide for the diagnosis and management of electrolyte disorders....
Information on diagnosis and management of 500 common or important medical and surgical disorders....
Product includes all 15 Lexi-Comps databases. Includes Lexi-drugs, the official reference of the American Pharmacists Association and the National Professional Society of Pharmacists....
... BD Safety Knife with BD Xstar Blade ... that protects the blade in prodedure and ... based on a grind-less process for manufacturing ... outstanding sharpness and consistency. The arch ...
Medicine Products: